Aim: Previous studies have found significant differences in clinical characteristics between pediatric and adult moyamoya disease (MMD) patients, but few studies have focused on the factors underlying these differences. We aimed to investigate Results: A total of 83 pediatric and 131 adult (1:1.6) MMD patients were analyzed.
| INTRODUC TI ON
Moyamoya disease (MMD) is characterized by progressive stenosis or occlusion of the bilateral internal carotid arteries (ICAs) with unknown etiology, and numerous collateral vessels appear at the base of the brain. 1 There is a bimodal peak age at onset for MMD, with peaks in childhood and adulthood, and the clinical features differ between these patients. 2 In contrast to adult patients with MMD, who often present with cerebral infarction, pediatric patients with MMD typically exhibit transient ischemic attack (TIA). 3 However, relatively little attention has been devoted to the causes of these differences.
Moyamoya disease has a chronic, irreversible, and progressive natural course. For MMD, progressive stenosis and occlusion of the principal intracranial artery lead not only to disease progression but also to the development of collateral circulation. Many studies have indicated that leptomeningeal collateral (LMC) status is a strong predictor of long-term functional outcomes in stroke patients with large vessel intracranial occlusion [4] [5] [6] and plays the most important role in the collateral supply of the ischemic cortex of the anterior cerebral artery (ACA) and middle cerebral artery (MCA) territory in MMD patients. 7 Although aging is a major risk factor for poor LMC status, 8 relatively little attention has been devoted to the differences and effects of LMC status in pediatric and adult MMD patients. Therefore, in this work, we sought to elucidate these differences and analyze their clinical value.
| ME THODS
The authors declare that all supporting data are available within the article and its online-only Data Supplements.
| Subjects
The ethics committee of our institution granted ethical approval for this retrospective study (ky-2018-6-60) and waived written informed consent.
We retrospectively reviewed bilateral MMD patients who were treated in our department between January 2014 and January 2016.
The patients included in this study met the following criteria: (a) all of the patients underwent digital subtraction angiography (DSA) and met the current diagnostic criteria recommended by the moyamoya disease guidelines from 2012 9 ; (b) to exclude moyamoya syndrome, the patients were required to exhibit no history of systemic diseases, such as atherosclerosis or immune system disease 9 ; (c) the patients had no history of prior bypass surgery; (d) patients with two or more atherogenic risk factors, such as hypertension, diabetes mellitus, dyslipidemia, heavy smoking, heavy drinking, and congenital anomaly, were excluded because of unclear influences on collateral circulation 10 ; (e) patients with severe posterior cerebral artery (PCA) involvement (stage 3 and 4 according to the Mugikura staging system) were excluded because of disturbed blood supply to the LMCs 11 ; (f) the patients' symptoms at onset were transient ischemic attack (TIA) and infarction, and patients were excluded if the details of the first clinical event could not be confirmed or if their symptoms did not match the imaging findings; and (g) pediatric patients were defined as patients under 18 years old (≤18).
| Clinical data collection
Demographic and clinical data were collected according to a standard protocol during the patient's first visit to our institution. The data included age, sex, onset symptoms, and age at onset of initial symptoms. Infarction was verified by magnetic resonance imaging (MRI) or computed tomography (CT). The progression of MMD was stratified into three stages with a modified Suzuki staging system. 1 Suzuki stages 1-2, 3-4, and 5-6 were recorded as the early, medium, and advanced stages of MMD, respectively.
| Leptomeningeal collateral assessment
Because the lesions in MMD usually involve the bilateral cerebral hemispheres, many collateral grading methods for the healthy side do not apply to the side affected by MMD. In this study, LMC status was graded using DSA as follows: good LMC status was defined as 
| Treatment and follow-up
Encephaloduroarteriosynangiosis (EDAS) was performed in 252 symptomatic hemispheres within 2 weeks after DSA, and the opposite hemisphere was usually revascularized 3 months after the first surgery, if required. Postoperative DSA was routinely performed 6-9 months after surgery. The effect of revascularization through EDAS was graded according to the following system described by 
| Statistical analyses
The Mann-Whitney U test was used to compare continuous vari- Corp., Almond, NY, USA), and P < 0.05 was considered statistically significant.
| RE SULTS

| Patient characteristics
A total of 279 consecutive confirmed bilateral MMD patients were identified in our hospital between January 2014 and January 2016.
A total of 24 pediatric and 41 adult patients with severe posterior cerebral artery (PCA) involvement (stage 3 and 4 according to the Mugikura staging system) were excluded. In total, 214 MMD patients (pediatric: adult patients = 1:1.6) were finally included. The demographic features of the 83 pediatric patients (male: female = 1:1, 9.4 ± 3.5 years) and 131 adult patients (male: female = 1:1.6, 37.1 ± 9.2 years) are summarized in Table 1 . The average interval from the onset of symptoms to angiography was 17.4 ± 19.1 months in pediatric patients and 23.7 ± 29.6 months in adult patients.
| Difference in clinical characteristics between pediatric and adult patients with ischemic MMD
The clinical presentations were significantly different between pediatric and adult patients (P < 0.001). Pediatric patients were more likely to have TIA (67/83, 81%), while adult patients were more likely to have infarction (67/131, 51%). A total of 263 (107 in pediatric patients and 156 in adult patients) symptomatic hemispheres were analyzed. The Suzuki stages showed no significant difference between adult and pediatric patients with MMD (P = 0.076). In the early and medium stages, pediatric patients were more likely to present with TIA (both P < 0.001) than adult patients, but there was no significant difference in clinical symptoms between these patient groups in the advanced stage (P = 0.651).
F I G U R E 1
The leptomeningeal collaterals in patients with moyamoya disease During an average follow-up time of 27.57 ± 9 months, five infarctions occurred in pediatric patients, and seven infarctions and one bleeding event occurred in adult patients, but no patients died. There was no significant difference in the postoperative stroke rate between pediatric and adult patients with MMD (P = 0.833).
| Difference in leptomeningeal collateral status between pediatric and adult patients with ischemic MMD
A significant difference in LMC status was found between the two patient groups; the prevalence of good LMC status in pediatric patients with MMD was higher than that in adult patients (P = 0.002, Table 1 ). The LMC status in different stages was further compared in Table 2 . There was no significant difference in LMC status in the advanced stage (Suzuki stage 5-6) between the two patient groups (P = 0.547), but in the early (Suzuki stage 1-2) and medium (Suzuki stage 3-4) stages, pediatric patients were more likely to have good LMCs (P = 0.047 and P = 0.001; Figure 2 ) than adult patients.
| Association between leptomeningeal collateral status and clinical characteristics
The associations of LMC status with clinical symptoms and prognosis in pediatric and adult patients with MMD are compared in Table 3 .
Good LMC status was significantly correlated with TIA in pediatric and adult patients (P < 0.001 and P = 0.017).
The postoperative angiographic findings showed that there was no correlation between Matsushima stage and LMC status in pediatric (P = 0.285) or adult patients (P = 0.133, Table 2 ) with MMD.
However, poorer LMC status was associated with significantly higher postoperative stroke rates in pediatric (P = 0.003) and adult patients (P = 0.043) with MMD.
| D ISCUSS I ON
In this study, we found that there were significant differences in clinical symptoms and LMC status between pediatric and adult MMD patients and that LMC status had a strong correlation with the severity of clinical symptoms and postoperative prognosis. In addition, in the early and medium stages of MMD, pediatric patients were more likely to have good LMCs than adult patients. This finding suggested that pediatric MMD patients might have the ability There is a bimodal age distribution of moyamoya disease, with the first peak occurring in the pediatric population, typically in the first decade of life, and a second peak occurring between 30 and 40 years of age. 13 Pediatric patients primarily suffer from ischemia symptoms, and adult patients typically experience intracranial hemorrhage. 2 A Korean study in 2010 revealed that ischemic symptoms, especially TIAs, are predominant (70%) 14 in pediatric patients.
Another epidemiological study in Japan (2012) showed that although TIA and infarction accounted for 60% of all cases, TIA mainly occurred in pediatric patients, while infarction had a higher incidence in adult patients. 15 In our study, we found that TIA was the major symptom in pediatric patients, whereas infarction was more prevalent among adult patients. Our results are consistent with those of previous studies and indicate that differences in clinical symptoms exist between pediatric and adult patients. The causes of these differences remain unclear, and few studies have investigated this issue.
The development of abundant collateral circulation is more common in MMD, a chronic progressive cerebrovascular disease, than in other ischemic cerebrovascular diseases. Previous studies have found that the collateral circulation, especially from the leptomeningeal system, plays the most important role in the collateral supply for MMD patients. 7 The presence of collateral flow via the posterior communicating artery is associated with a low prevalence of border zone infarcts, 16 while stenosis or occlusion of the PCA is often associated with a high stroke rate in MMD patients. 17 Almost no LMCs from the PCA were observed in normal hemispheres without ACA or MCA stenosis/occlusion. In our study, we found that the prevalence of good LMCs was higher in pediatric patients than in adult patients during the early and medium MMD stages, and poor LMC status had a strong correlation with severe clinical symptoms, such as infarction, in the medium stage. This finding reveals that the intracranial collateral circulation plays an important role in the differences in clinical symptoms between pediatric and adult MMD patients. Therefore, we conclude that good intracranial collateral compensation could improve cerebrovascular reserve and tolerance to cerebral ischemia and lead to milder symptoms at onset and lower incidence rates of stroke in pediatric patients.
The mechanism for the differences in LMC status between pediatric and adult MMD patients in the same stage remains unclear.
Experimental studies have shown that aging causes a significant decrease in LMCs, as well as increased tortuosity and vascular resistance in leptomeningeal vessels. 18, 19 It is also well established from human studies that age has a detrimental effect on cerebrovascular reactivity. 20 Therefore, age may be an important influencing factor for collateral development. Second, focal cerebral ischemia may stimulate collateral growth via the secretion of cytokines, such as angiogenic peptides 21 and vascular endothelial growth factor (VEGF). 22 Some studies have shown that VEGF levels are lower in aged individuals than in young individuals. 23 Third, common concomitant diseases in adult MMD patients, such as hypertension, have been shown to affect the development of collaterals in rats. 24 In this study, we also discovered that poor LMC status had a strong correlation with postoperative stroke. Previous studies have shown that LMCs are important for hemodynamic status. 25 Therefore, be- There are several limitations of our work. One limitation is that all patients were enrolled from a single neurosurgery center, and 26 and due to the barriers of the cerebrospinal fluid and skull, it was difficult to establish collaterals between the external carotid artery (ECA) and the ICA. 27 Therefore, we believe that LMCs might be more important in the early and medium MMD stages in both pediatric and adult patients. In our study, we described only the association between LMCs and clinical characteristics. Further studies are needed to explore this relationship, such as investigations of cerebral hemodynamics in moyamoya disease using multiple inversion time arterial spin labeling MRI. Moreover, the mechanisms underlying the difference in the prevalence of good LMCs between pediatric and adult patients remain unclear and require further study. 
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